After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Relay Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Relay Therapeutics Inc is $843.01M. A total of 0.77 million shares were traded on the day, compared to an average of 1.21M shares.
In the most recent transaction, Bergstrom Donald A sold 765 shares of RLAY for 7.70 per share on Mar 27 ’24. After the transaction, the President, R&D now owns 530,113 company shares. In a previous transaction on Mar 27 ’24, Catinazzo Thomas sold 348 shares at 7.70 per share. RLAY shares that Chief Financial Officer owns now total 341,498.
Among the insiders who sold shares, Adams Brian disposed of 348 shares on Mar 27 ’24 at a per-share price of $7.70. This resulted in the Chief Legal Officer holding 327,390 shares of RLAY after the transaction. In another insider transaction, Rahmer Peter sold 298 shares at $7.70 per share on Mar 27 ’24. Company shares held by the insider now total 514,679.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RLAY has a high of $13.32 and a low of $5.70.
As of this writing, RLAY has an earnings estimate of -$0.71 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.63 per share and a lower estimate of -$0.81. The company reported an EPS of -$0.78 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $5.90, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.67.
